Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

586 Articles

Douglas A. McIntyre | Dec 10, 2007 at 4:57 PM EST

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the…

Douglas A. McIntyre | Dec 6, 2007 at 4:10 AM EST

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

According to Reuters, Nikon is seeing a sharp increase in demand from LCD makers.Reuters writes that the housing slump will…

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today.All of the talk up front…

Douglas A. McIntyre | Nov 4, 2007 at 5:28 PM EST

A Little Trouble For Bristol-Myers (BMY) Plavix

Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4…

Douglas A. McIntyre | Oct 17, 2007 at 7:51 AM EDT

Medarex Hit With Sell Rating (MEDX, BMY)

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL"…

Douglas A. McIntyre | Oct 12, 2007 at 1:05 PM EDT

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. …

Douglas A. McIntyre | Oct 8, 2007 at 3:17 AM EDT

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Morgan Stanley (MS) plans to start a wealth management business in India.Reuters writes that Alan Greenspan said…

Douglas A. McIntyre | Sep 25, 2007 at 3:08 AM EDT

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft (MSFT) launched its Halo 3 game which is essential to driving Xbox sales.Reuters writes that the…

Douglas A. McIntyre | Sep 11, 2007 at 7:22 AM EDT

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival…

Douglas A. McIntyre | Aug 28, 2007 at 9:19 AM EDT

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s,…

Douglas A. McIntyre | Aug 22, 2007 at 11:04 AM EDT

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000…

Douglas A. McIntyre | Jun 25, 2007 at 6:24 AM EDT

Earlybird Analyst Calls (June 25, 2007)

Stock Tickers: ABI, BBSI, BMY, CAP, CLUB, CVX, FCBP, GM, IPG, OMC, MIG, PER, PIR, SKH, SMSI, TRLGABI raised to…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 20, 2007 at 3:20 AM EDT

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft (MSFT) will alter its Vista operating system so that it works better with Google (GOOG) and…

Douglas A. McIntyre | Jun 19, 2007 at 7:11 AM EDT

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement…

1 … 37 38 39 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earlybird Analyst Calls (June 25, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pre-Market Stock News (June 19, 2007)

After Reviewing Every International Developed Market ETF These 3 Cover Japan and Europe Better Than Anything Else

Emerging Markets Are Delivering Over 22 Percent Returns and Most American Investors Are Missing It Entirely

Why SOXX’s Next 12 Months Hinge on Five Tech Giants’ Capex Decisions

The RMD Trap: How a Single $95,000 Withdrawal Blindsided a 73-Year-Old's Medicare Costs

The Roth Conversion That Added $999.60 to a Retiree's Medicare Bill...Two Years Later

After Reviewing Every International Developed Market ETF These 3 Cover Japan and Europe Better Than Anything Else

Emerging Markets Are Delivering Over 22 Percent Returns and Most American Investors Are Missing It Entirely

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earlybird Analyst Calls (June 25, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pre-Market Stock News (June 19, 2007)

After Reviewing Every International Developed Market ETF These 3 Cover Japan and Europe Better Than Anything Else

Emerging Markets Are Delivering Over 22 Percent Returns and Most American Investors Are Missing It Entirely

Why SOXX’s Next 12 Months Hinge on Five Tech Giants’ Capex Decisions

Featured Reads

The RMD Trap: How a Single $95,000 Withdrawal Blindsided a 73-Year-Old's Medicare Costs

The Roth Conversion That Added $999.60 to a Retiree's Medicare Bill...Two Years Later